China has criticized the U.S. for intensifying restrictions on its semiconductor industry, warning that such actions will ultimately backfire. The Chinese foreign ministry accused Washington of pressuring other nations to target China’s chip sector, which it says will disrupt global semiconductor development.
Foreign ministry spokesperson Lin Jian stated during a regular press briefing on Tuesday that the U.S. strategy to curb China’s semiconductor progress would not only hinder technological growth but also create instability in the global supply chain. He emphasized that such coercion goes against fair competition and free trade principles.
The Biden administration has been tightening chip restrictions on China, aiming to limit its access to advanced semiconductor technology. The latest move includes potential new rules that could further restrict U.S. companies from supplying critical chipmaking equipment to Chinese firms. Washington argues these measures are necessary for national security, but Beijing sees them as an attempt to suppress its technological rise.
China has consistently opposed U.S. efforts to block its chip advancements, warning that these restrictions will harm American businesses and global industry players. The ongoing tech war between the two nations has intensified as the U.S. continues to rally allies in its push against China’s semiconductor ambitions.
As competition in the semiconductor industry escalates, global markets remain on edge, with potential repercussions for supply chains and innovation. Experts warn that restricting China’s chip access could disrupt production worldwide, affecting industries reliant on semiconductors, from consumer electronics to artificial intelligence.
While the U.S. seeks to maintain its technological edge, China remains firm in its stance, vowing to push forward with independent innovation despite mounting challenges.


Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Adobe Strengthens AI Strategy Ahead of Q4 Earnings, Says Stifel
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans
Trump Signs Executive Order to Establish National AI Regulation Standard
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Nvidia Develops New Location-Verification Technology for AI Chips
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO 



